"Together we will create a world without Alzheimer’s disease – a devastating condition that takes memories and lives. Since 2001 the Foundation has provided significant support to the work of acclaimed researchers undertaking leading edge projects. Director of Research Prof Ralph Martins AO, is an internationally recognised scientist, Professor of Alzheimer’s and Ageing at Edith Cowan University, and was awarded WA Australian of the Year in 2010."

During the past decade, Australian Alzheimer's Research Foundation conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Australian Alzheimer's Research Foundation" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "AstraZeneca" with 2 trials sponsored, "Athira Pharma" with 2 trials sponsored, "Eisai Inc." with 2 trials sponsored and "Actinogen Medical" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Australian Alzheimer's Research Foundation" #1 collaborator was "Biogen" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Alzheimer's Clinical Trials Consortium" with 1 trials as a collaborator and "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Australian Alzheimer's Research Foundation" are "Alzheimer Disease" (5 trials), "Alzheimer's Disease" (4 trials), "Alzheimers Disease" (1 trials), "Alzheimer´s Disease" (1 trials) and "Dementia of Alzheimer Type" (1 trials). Many other conditions were trialed in "Australian Alzheimer's Research Foundation" in a lesser frequency.

Most popular intervention types in "Australian Alzheimer's Research Foundation" are "Drug" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Gantenerumab" (5 trials), "ATH-1017" (2 trials), "Lanabecestat" (2 trials) and "Lecanemab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Australian Alzheimer's Research Foundation" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Australian Alzheimer's Research Foundation". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Australian Alzheimer's Research Foundation, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Australian Alzheimer's Research Foundation, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Australian Alzheimer's Research Foundation has several departments that took part in Clinical trials: "The McCusker Foundation for Alzheimer's Disease Research" - 2 trials